Blood transcriptomic signatures predict poor treatment outcomes in drug-susceptible pulmonary TB in Brazil.

Mendelsohn SC, Andrade BB, Araújo-Pereira M, Amorim GC, Erasmus M, Andrade AM, Fisher M, Figueiredo MC, Muwanga VM, Kritski AL, Cordeiro-Santos M, Rolla VC, Hatherill M, Sterling TR, Scriba TJ, members of the RePORT South Africa, RePORT-Brazil Consortia

Open source

DOI: 10.1101/2025.10.07.25337480
Published: 2025 Oct 8
Container: medRxiv : the preprint server for health sciences
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1101/2025.10.07.25337480,
  title = {Blood transcriptomic signatures predict poor treatment outcomes in drug-susceptible pulmonary TB in Brazil.},
  author = {Mendelsohn SC and Andrade BB and Araújo-Pereira M and Amorim GC and Erasmus M and Andrade AM and Fisher M and Figueiredo MC and Muwanga VM and Kritski AL and Cordeiro-Santos M and Rolla VC and Hatherill M and Sterling TR and Scriba TJ and members of the RePORT South Africa and RePORT-Brazil Consortia},
  year = {2025},
  journal = {medRxiv : the preprint server for health sciences},
  doi = {10.1101/2025.10.07.25337480},
  url = {https://doi.org/10.1101/2025.10.07.25337480}
}

RIS

TY  - JOUR
TI  - Blood transcriptomic signatures predict poor treatment outcomes in drug-susceptible pulmonary TB in Brazil.
AU  - Mendelsohn SC
AU  - Andrade BB
AU  - Araújo-Pereira M
AU  - Amorim GC
AU  - Erasmus M
AU  - Andrade AM
AU  - Fisher M
AU  - Figueiredo MC
AU  - Muwanga VM
AU  - Kritski AL
AU  - Cordeiro-Santos M
AU  - Rolla VC
AU  - Hatherill M
AU  - Sterling TR
AU  - Scriba TJ
AU  - members of the RePORT South Africa
AU  - RePORT-Brazil Consortia
PY  - 2025
JO  - medRxiv : the preprint server for health sciences
DO  - 10.1101/2025.10.07.25337480
UR  - https://doi.org/10.1101/2025.10.07.25337480
ER  -

APA

SC, M., BB, A., M, A., GC, A., M, E., AM, A., M, F., MC, F., VM, M., AL, K., M, C., VC, R., M, H., TR, S., TJ, S., Africa, M. O. T. R. S., & Consortia, R. (2025). Blood transcriptomic signatures predict poor treatment outcomes in drug-susceptible pulmonary TB in Brazil.. medRxiv : the preprint server for health sciences. https://doi.org/10.1101/2025.10.07.25337480

Source records

pubmed · retrieved 2026-09-27T13:17:54.395Z